Isotretinoin and Risk for Inflammatory Bowel Disease
Mahyar Etminan(Oncolytics Biotech (Canada)), James M. Brophy(McGill University Health Centre), Joseph A. Delaney(Center for Drug Evaluation and Research), Brian Bressler(University of British Columbia), Steven T. Bird(United States Food and Drug Administration)
Cited by 93
Related Papers
Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data
|BMJ|2017|525
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
|Canadian Medical Association Journal|2012|120
Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells
|Gastroenterology|2019|103
Risk of acute kidney injury associated with the use of fluoroquinolones
|Canadian Medical Association Journal|2013|89
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
|Clinical Microbiology and Infection|2022|89